Home » Stocks » ELTP

Elite Pharmaceuticals, Inc. (ELTP)

Stock Price: $0.0523 USD -0.0043 (-7.60%)
Updated Apr 15, 2021 1:31 PM EDT - Market open
Market Cap 56.51M
Revenue (ttm) 25.93M
Net Income (ttm) 6.51M
Shares Out 1.01B
EPS (ttm) 0.01
PE Ratio 7.47
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 15
Last Price $0.0523
Previous Close $0.0566
Change ($) -0.0043
Change (%) -7.60%
Day's Open 0.0532
Day's Range 0.0523 - 0.0569
Day's Volume 204,470
52-Week Range 0.0480 - 0.0995


NORTHVALE, NJ / ACCESSWIRE / January 5, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products...

3 months ago - Accesswire

About ELTP

Elite Pharmaceuticals, Inc. engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Hydromorphone HCl 8mg tablets fo... [Read more...]

Drug Manufacturers-Specialty & Generic
IPO Date
Jul 23, 1998
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2019, ELTP's revenue was $17.99 million, an increase of 137.76% compared to the previous year's $7.57 million. Losses were -$2.24 million, -75.86% less than in 2018.

Financial Statements